Aurora Cannabis Stock (NASDAQ:ACB)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$4.10

52W Range

$2.84 - $9.35

50D Avg

$4.93

200D Avg

$5.60

Market Cap

$234.33M

Avg Vol (3M)

$933.62K

Beta

2.70

Div Yield

-

ACB Company Profile


Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

1,073

IPO Date

Jul 15, 2014

Website

ACB Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceJun 22Jun 21Jun 20
European Union$61.52M$29.98M$21.53M
Country of domicile$159.46M--
Other Geographical Areas$359.00K$4.20M$2.10M

Fiscal year ends in Mar 23 | Currency in CAD

ACB Financial Summary


Mar 23Jun 22Jun 21
Revenue$233.29M$221.34M$245.25M
Operating Income$-254.32M$-231.45M$-282.82M
Net Income$-265.33M$-1.72B$-693.63M
EBITDA$-210.74M$-143.09M$-137.20M
Basic EPS$-8.22$-7.99$-41.01
Diluted EPS$-8.22$-7.99$-41.01

Fiscal year ends in Mar 23 | Currency in CAD

Latest Earnings Call Transcripts


Q2 25Nov 06, 24 | 9:37 AM
Q1 25Aug 07, 24 | 10:41 AM
Q4 24Jun 20, 24 | 11:00 AM

Peer Comparison


TickerCompany
TLRYTilray Brands, Inc.
CGCCanopy Growth Corporation
SNDLSNDL Inc.
OGIOrganiGram Holdings Inc.
CRONCronos Group Inc.